An outside party gained access to some company systems, but the medical device maker found no evidence that sensitive or protected data was obtained and said its operations are running normally.
Talkspace will retain its brand, structure and broader strategic direction while operating as a wholly owned subsidiary of the brick-and-mortar acute and behavioral care provider. Executives said they expect both businesses to benefit from bidirectional patient referrals.
Since April, more than 300 enterprise health systems have adopted Abridge's artificial intelligence-based decision support solution, and the company is now making the tool available to every clinician at its partner health systems.
Women’s health startups should plan for reimbursement early, as limited research and evidence can make securing coverage difficult, a new report explains. The post The Reimbursement Challenges Hurting Women’s Health Companies, Per Milken Institute appeared first on MedCity News .
Vogenx’s mizagliflozin is heading into Phase 2b testing for post-bariatric hypoglycemia (PBH). Amylyx Pharmaceuticals and Recordati are developing injectable peptide drugs for this metabolic disorder, but Vogenx aims to stand apart by offering patients a different mechanism of action and…
(MedPage Today) -- "Same disease, very different access." -- Fei Wang, PhD, of Breakthrough T1D in St. Leonards, Australia, discussing the state-by-state disparities in the U.S. in terms of type 1 diabetes incidence and access to pediatric endocrinologists...
Sen. Bill Cassidy (R-La.) on Sunday said President Trump's executive order that seeks to alter the childhood vaccine schedule is based on "crazy, stupid" claims, and that is "why the president's poll numbers are going down." During Cassidy's appearance on…
The bottleneck in AI-enabled real-world data analysis is not computation, model architecture, or training data volume. It is the semantic layer over which the AI is trying to reason – the place where precise clinical meaning lives. The post Better…
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is that not only is this terrible for patient health, it can be more costly in…